Hepion Pharmaceuticals, Inc. (HEPA)
0.14
0.00 (0.00%)
USD |
OTCM |
Oct 23, 16:00
Hepion Pharmaceuticals Enterprise Value : 4.143M for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 4.143M |
| October 22, 2026 | 3.998M |
| October 21, 2026 | 3.641M |
| October 20, 2026 | 3.561M |
| October 19, 2026 | 3.040M |
| October 16, 2026 | 3.083M |
| October 15, 2026 | 2.926M |
| October 14, 2026 | 2.721M |
| October 13, 2026 | 1.843M |
| October 12, 2026 | 3.663M |
| October 09, 2026 | 3.561M |
| October 08, 2026 | 3.706M |
| October 07, 2026 | 3.561M |
| October 06, 2026 | 3.561M |
| October 05, 2026 | 2.978M |
| October 02, 2026 | 2.425M |
| October 01, 2026 | 2.978M |
| September 30, 2026 | 3.373M |
| September 29, 2026 | 3.270M |
| September 28, 2026 | 2.396M |
| September 25, 2026 | 2.612M |
| September 24, 2026 | 2.283M |
| September 23, 2026 | 1.901M |
| September 22, 2026 | 2.367M |
| September 21, 2026 | 2.390M |
| Date | Value |
|---|---|
| September 18, 2026 | 2.306M |
| September 17, 2026 | 2.156M |
| September 16, 2026 | 2.082M |
| September 15, 2026 | 2.367M |
| September 14, 2026 | 2.367M |
| September 11, 2026 | 2.122M |
| September 10, 2026 | 2.250M |
| September 09, 2026 | 1.726M |
| September 08, 2026 | 2.629M |
| September 04, 2026 | 2.629M |
| September 03, 2026 | 1.988M |
| September 02, 2026 | 2.136M |
| September 01, 2026 | 2.250M |
| August 31, 2026 | 2.382M |
| August 28, 2026 | 2.833M |
| August 27, 2026 | 1.610M |
| August 26, 2026 | 1.959M |
| August 25, 2026 | 2.221M |
| August 24, 2026 | 1.843M |
| August 21, 2026 | 2.250M |
| August 20, 2026 | 2.250M |
| August 19, 2026 | 2.250M |
| August 18, 2026 | 2.250M |
| August 17, 2026 | 2.250M |
| August 14, 2026 | 2.250M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| ANI Pharmaceuticals, Inc. | 1.903B |
| Corcept Therapeutics, Inc. | 8.967B |
| Veru, Inc. | 15.08M |
| Johnson & Johnson | 662.44B |
| Eli Lilly & Co. | 1.245T |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.248M |
| Total Expenses (Quarterly) | 1.248M |
| EPS Diluted (Quarterly) | -0.0771 |
| Earnings Yield | -174.4% |
| Normalized Earnings Yield | -173.07 |